1. Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. Issue 1 (13th October 2009) Authors: Kijanka, G; Hector, S; Kay, E W; Murray, F; Cummins, R; Murphy, D; MacCraith, B D; Prehn, J H M; Kenny, D Journal: Gut Issue: Volume 59:Issue 1(2010) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TARGETING THE 19S PROTEASOMAL SUBUNIT, RPT4, IN COLON CANCER CELLS INDUCES CELL DEATH AND REDUCES CELLULAR PROLIFERATION IN VITRO AND IN VIVO. (8th June 2013) Authors: Boland, K; McCawley, N; Ryan, D; Hector, S; Kay, E; McNamara, D; Murray, F; Concannon, C G; Prehn, J H M Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗